Japan's relaxing of device stability testing rules will shorten approval lag
This article was originally published in RAJ Devices
Executive Summary
Companies seeking regulatory approval for their medical devices in Japan no longer have to submit stability testing data to establish the expiration period of the product unless the technologies are highly-specialised and novel. This move, which is much-welcomed by industry, removes one of the biggest hurdles in Japan's notoriously convoluted regulatory system and is expected to significantly shorten the country's problematic device lag, the delay in approval of new medical devices between Japan and the US/Europe.